MedPath

Effectiveness of eHealth on the Self-management of Health Status and QOL Among CAD Patients

Not Applicable
Completed
Conditions
eHealth
Self-management
Coronary Artery Disease
Quality of Life
Registration Number
NCT04146766
Lead Sponsor
National Defense Medical Center, Taiwan
Brief Summary

This article uses the smart medical case management tracking system, combined with various terminal devices to fully record the measured data (pulse, blood pressure) for case home care tracking to prevent the occurrence and deterioration of the disease. Therefore, with the promotion of the eHealth medical staff and members of the family can instantly grasp the health of the body and cultivate the habits of self-health management and enhance the quality of care. Therefore, we hope to use the Smart Health Cloud as an interventional measure to improve the care of patients with coronary artery disease, improve self-management ability and quality of life.

Detailed Description

The World Health Organization points out that cardiovascular disease is the number one killer of global deaths, killing 17.1 million people worldwide each year, accounting for 31% of the world's total deaths. Heart disease is the second leading cause of death in China. Coronary artery disease (CAD) is the majority, and coronary artery disease is the most common cardiovascular disease. Good self-management can reduce disease risk factors and improve related prognosis. It is also an important issue in health promotion around the world. This article uses the smart medical case management tracking system, combined with various terminal devices to fully record the measured data (pulse, blood pressure) for case home care tracking to prevent the occurrence and deterioration of the disease. Therefore, with the promotion of the eHealth medical staff and members of the family can instantly grasp the health of the body and cultivate the habits of self-health management and enhance the quality of care. Therefore, we hope to use the Smart Health Cloud as an interventional measure to improve the care of patients with coronary artery disease, improve self-management ability and quality of life.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • A patient who is 20 years of age or older and has a Coronary computed tomography angiography >50% vascular stenosis, has been PTCA、stent or CABG
  • Taiwanese, understand Chinese
Exclusion Criteria
  • Those who can't express their wishes clearly (such as Azheimer's disease, mental dysfunction)
  • mental disorder
  • infectious diseases
  • Patients who participate in other research projects

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
physiological indicators-HbA1C(T3)T3-six months later

HbA1C, the unit is %

physiological indicators-Total Cholesterol(T1)T1-baseline

Total Cholesterol, the unit is mg/dL

physiological indicators-Total Cholesterol(T3)T3-six months later

Total Cholesterol, the unit is mg/dL

physiological indicators-Triglyceride(T1)T1-baseline

Triglyceride, the unit is mg/dL

physiological indicators-GLU(T3)T3-six months later

GLU, the unit is mg/dL

physiological indicators-HbA1C(T1)T1-baseline

HbA1C, the unit is %

physiological indicators-LDL-C(T3)T3-six months later

LDL-C, the unit is mg/dL

physiological indicators-GLU(T2)T2-three months later

GLU, the unit is mg/dL

physiological indicators-HDL-C(T2)T2-three months later

HDL-C, the unit is mg/dL

physiological indicators-HDL-C(T3)T3-six months later

HDL-C, the unit is mg/dL

physiological indicators-Triglyceride(T3)T3-six months later

Triglyceride, the unit is mg/dL

physiological indicators-LDL-C(T1)T1-baseline

LDL-C, the unit is mg/dL

physiological indicators-GLU(T1)T1-baseline

GLU, the unit is mg/dL

physiological indicators-HbA1C(T2)T2-three months later

HbA1C, the unit is %

physiological indicators-LDL-C(T2)T2-three months later

LDL-C, the unit is mg/dL

physiological indicators-Total Cholesterol(T2)T2-three months later

Total Cholesterol, the unit is mg/dL

physiological indicators-Triglyceride(T2)T2-three months later

Triglyceride, the unit is mg/dL

physiological indicators-HDL-C(T1)T1-baseline

HDL-C, the unit is mg/dL

Secondary Outcome Measures
NameTimeMethod
self-management-T2T2-three months later

use The partners in Health scale. total of 12 questions,The scoring method uses the nine-point Likert Scales score. The score of 0 is divided into self-management performance, and the score of 8 indicates that self-management is good. The total score is 96 points. The higher the score, the better the self-management.

self-management-T1T1-baseline

use The partners in Health scale. total of 12 questions,The scoring method uses the nine-point Likert Scales score. The score of 0 is divided into self-management performance, and the score of 8 indicates that self-management is good. The total score is 96 points. The higher the score, the better the self-management.

self-management-T3T3-six months later

use The partners in Health scale. total of 12 questions,The scoring method uses the nine-point Likert Scales score. The score of 0 is divided into self-management performance, and the score of 8 indicates that self-management is good. The total score is 96 points. The higher the score, the better the self-management.

Trial Locations

Locations (1)

TSGH

🇨🇳

Taipei city, Taiwan

TSGH
🇨🇳Taipei city, Taiwan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.